市场调查报告书

分子生物学用酵素、套件、试剂的全球市场 - 成长,趋势,预测(2018年~2023年)

Molecular Biology Enzymes, Kits and Reagents Market - Growth, Trends, and Forecast (2020 - 2025)

出版商 Mordor Intelligence LLP 商品编码 708599
出版日期 内容资讯 英文 120 Pages
商品交期: 2-3个工作天内
价格
分子生物学用酵素、套件、试剂的全球市场 - 成长,趋势,预测(2018年~2023年) Molecular Biology Enzymes, Kits and Reagents Market - Growth, Trends, and Forecast (2020 - 2025)
出版日期: 2020年02月01日内容资讯: 英文 120 Pages
简介

全球分子生物学用酵素、套件、试剂市场在2018年到2023年间,预测将以15.4%的年复合成长率扩大。

本报告提供分子生物学用酵素、套件、试剂的全球市场调查,市场概要,各类型、用途、终端用户、地区的市场趋势,市场规模的变化与预测,市场促进、阻碍因素以及市场机会分析,竞争情形,主要企业的简介等全面性资讯。

目录

第1章 简介

  • 市场定义

第2章 调查方法

第3章 摘要整理

第4章 主要影响要素

第5章 市场概要

  • 市场方案
  • 波特的五力分析
    • 供应商谈判力
    • 消费者谈判力
    • 新加入厂商的威胁
    • 替代产品与服务的威胁
    • 产业内的竞争

第6章 市场动态

  • 市场成长要素
  • 市场阻碍因素
  • 市场机会
  • 主要课题

第7章 市场区隔

  • 各产品
    • 套件
    • 酵素
  • 各用途
    • 聚合酵素链锁反应
    • 定序
    • 基因复制
    • 表觀遗传学
    • 限制消化
    • 其他
  • 各终端用户
    • 学术研究机关
    • 医药品、生物科技企业
    • 医院、诊断中心
    • 其他
  • 各地区
    • 北美
    • 欧洲
    • 亚太地区
    • 中东、非洲
    • 南美

第8章 企业简介

  • Agilent Technologies
  • F. Hoffmann-La Roche Ltd
  • Illumina Inc.
  • Lucigen Corporation
  • Merck KGaA
  • New England Biolabs Inc.
  • Promega Corporation
  • Qiagen NV
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.

第9章 市场未来展望

本网页内容可能与最新版本有所差异。详细情况请与我们联系。

目录
Product Code: 64141

Research & Development (R&D) is defined as the process of creating new products, processes, and technologies that can be used and marketed for mankind's benefit in the future. The increase in R&D investment in Asia, particularly China, and the consecutive annual growth in R&D spending in North America indicate a period of stability, security, and healthy competition, across the industrial sectors. As per the 2019 Global R&D funding forecast, the annual study published by R&D magazine, a publication of Advantage Business Marketing revealed that global R&D investment has increased by around 3.6% in 2019 to a total of USD 2.3 trillion, in purchasing power parity (PPP) values for the more than 110 countries having significant R&D investments (more than $100 million). Thus, increased research and R&D investments in the life science industry are augmenting the growth of the market.

In addition, technological advancements, and rising incidence of infectious diseases and genetic disorders are some factors that are spurring the growth of the market.

Key Market Trends

Polymerase Chain Reaction Segment is Expected to Show Better Growth in the Forecast Years

Based on the Application, it is segmented into polymerase chain reaction (PCR), sequencing, epigenetics, and other applications. The growth of the segment is mainly attributed to the increasing prevalence of genetic, infectious, and chronic diseases. PCR based tests are increasingly being used to guide patient management, particularly in the fields of infectious disease, cancer, and congenital abnormalities. According to the WHO, cancer is the second leading cause of death globally and is responsible for an estimated 9.6 million deaths in 2018. The PCR techniques are routinely used for tumor profiling and detection of bacterial infections. Pertaining to broad applications of PCR in the field of molecular biology, the market segment is expected to show better growth during the forecast period.

North America is Expected to Dominate the Market

The molecular biology enzymes, kits and reagents market dominates the North America region due to increasing prevalence of genetic and chronic disorders, such as cancer, and favorable government initiatives. According to the American Cancer Society, approximately 1,735,350 new cancer cases were diagnosed in the United States in 2018 and there were around 609,640 deaths during the same year. Furthermore, growing geriatric population, along with rising R&D activities in the region is expected to drive the market over the forecast period.

Competitive Landscape

The global players into the molecular biology enzymes, kits, and reagents market are Agilent Technologies, Inc., F.Hoffmann-La Roche Ltd., Illumina, Inc., Lucigen Corporation, Merck KGaA, New England Biolabs, Promega Corporation, Qiagen NV, Takara Bio Inc. and Thermo Fisher Scientific.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Incidence of Infectious Diseases and Genetic Disorders
    • 4.2.2 Increasing R&D Activities in the Life Science Industry
    • 4.2.3 Technological Advancements
  • 4.3 Market Restraints
    • 4.3.1 High Cost and Limited Reimbursements for Genetic Testing
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product
    • 5.1.1 Enzymes
    • 5.1.2 Kits and Reagents
  • 5.2 By Application
    • 5.2.1 Polymerase Chain Reaction
    • 5.2.2 Sequencing
    • 5.2.3 Epigenetics
    • 5.2.4 Other Applications
  • 5.3 By End Users
    • 5.3.1 Hospitals and Diagnostic Centers
    • 5.3.2 Academic and Research Institutes
    • 5.3.3 Pharmaceutical and Biotechnology Companies
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle-East and Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle-East and Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Agilent Technologies
    • 6.1.2 F. Hoffmann-La Roche Ltd
    • 6.1.3 Illumina Inc.
    • 6.1.4 Lucigen Corporation
    • 6.1.5 Merck KGaA
    • 6.1.6 New England Biolabs
    • 6.1.7 Promega Corporation
    • 6.1.8 Qiagen NV
    • 6.1.9 Takara Bio Inc.
    • 6.1.10 Thermo Fisher Scientific

7 MARKET OPPORTUNITIES AND FUTURE TRENDS